BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 19360336)

  • 1. Adenovirus-mediated eukaryotic initiation factor 4E binding protein-1 in combination with rapamycin inhibits tumor growth of pancreatic ductal adenocarcinoma in vivo.
    Mishra R; Miyamoto M; Yoshioka T; Ishikawa K; Matsumura Y; Shoji Y; Ichinokawa K; Itoh T; Shichinohe T; Hirano S; Kondo S
    Int J Oncol; 2009 May; 34(5):1231-40. PubMed ID: 19360336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical correlates of mTOR inhibition by the rapamycin ester CCI-779 and tumor growth inhibition.
    Dudkin L; Dilling MB; Cheshire PJ; Harwood FC; Hollingshead M; Arbuck SG; Travis R; Sausville EA; Houghton PJ
    Clin Cancer Res; 2001 Jun; 7(6):1758-64. PubMed ID: 11410517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways.
    Liu L; Li F; Cardelli JA; Martin KA; Blenis J; Huang S
    Oncogene; 2006 Nov; 25(53):7029-40. PubMed ID: 16715128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of p-4E-BP1 and p-eIF4E on cell proliferation in a breast cancer model.
    Pons B; Peg V; Vázquez-Sánchez MA; López-Vicente L; Argelaguet E; Coch L; Martínez A; Hernández-Losa J; Armengol G; Ramon Y Cajal S
    Int J Oncol; 2011 Nov; 39(5):1337-45. PubMed ID: 21750861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of 4E-BP1 sensitizes U87 glioblastoma xenograft tumors to irradiation by decreasing hypoxia tolerance.
    Dubois L; Magagnin MG; Cleven AH; Weppler SA; Grenacher B; Landuyt W; Lieuwes N; Lambin P; Gorr TA; Koritzinsky M; Wouters BG
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1219-27. PubMed ID: 19251093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic tumours escape from translational control through 4E-BP1 loss.
    Martineau Y; Azar R; Müller D; Lasfargues C; El Khawand S; Anesia R; Pelletier J; Bousquet C; Pyronnet S
    Oncogene; 2014 Mar; 33(11):1367-74. PubMed ID: 23563181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rapamycin-sensitive signal transduction pathway as a target for cancer therapy.
    Hidalgo M; Rowinsky EK
    Oncogene; 2000 Dec; 19(56):6680-6. PubMed ID: 11426655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the phosphorylation and integrity of protein synthesis initiation factor eIF4GI and the translational repressor 4E-BP1 by p53.
    Constantinou C; Clemens MJ
    Oncogene; 2005 Jul; 24(30):4839-50. PubMed ID: 15897901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the eukaryotic translation initiation factor 4E (eIF4E) and 4E-BP1 in esophageal cancer.
    Salehi Z; Mashayekhi F
    Clin Biochem; 2006 Apr; 39(4):404-9. PubMed ID: 16375881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenethyl isothiocyanate, a cancer chemopreventive constituent of cruciferous vegetables, inhibits cap-dependent translation by regulating the level and phosphorylation of 4E-BP1.
    Hu J; Straub J; Xiao D; Singh SV; Yang HS; Sonenberg N; Vatsyayan J
    Cancer Res; 2007 Apr; 67(8):3569-73. PubMed ID: 17440067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different roles for the TOS and RAIP motifs of the translational regulator protein 4E-BP1 in the association with raptor and phosphorylation by mTOR in the regulation of cell size.
    Eguchi S; Tokunaga C; Hidayat S; Oshiro N; Yoshino K; Kikkawa U; Yonezawa K
    Genes Cells; 2006 Jul; 11(7):757-66. PubMed ID: 16824195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation enhances adenoviral gene therapy in pancreatic cancer via activation of cytomegalovirus promoter and increased adenovirus uptake.
    Egami T; Ohuchida K; Mizumoto K; Onimaru M; Toma H; Nishio S; Nagai E; Matsumoto K; Nakamura T; Tanaka M
    Clin Cancer Res; 2008 Mar; 14(6):1859-67. PubMed ID: 18347189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus infection inactivates the translational inhibitors 4E-BP1 and 4E-BP2.
    Gingras AC; Sonenberg N
    Virology; 1997 Oct; 237(1):182-6. PubMed ID: 9344920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of translation factors eIF4GI and 4E-BP1 during recovery of protein synthesis from inhibition by p53.
    Constantinou C; Clemens MJ
    Cell Death Differ; 2007 Mar; 14(3):576-85. PubMed ID: 16990847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined transcriptional and translational targeting of EWS/FLI-1 in Ewing's sarcoma.
    Mateo-Lozano S; Gokhale PC; Soldatenkov VA; Dritschilo A; Tirado OM; Notario V
    Clin Cancer Res; 2006 Nov; 12(22):6781-90. PubMed ID: 17121899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrin induces phosphorylation of eIF4E binding protein 1 and translation initiation of ornithine decarboxylase mRNA.
    Pyronnet S; Gingras AC; Bouisson M; Kowalski-Chauvel A; Seva C; Vaysse N; Sonenberg N; Pradayrol L
    Oncogene; 1998 Apr; 16(17):2219-27. PubMed ID: 9619831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell signaling in endometrial carcinoma: phosphorylated 4E-binding protein-1 expression in endometrial cancer correlates with aggressive tumors and prognosis.
    Castellvi J; Garcia A; Ruiz-Marcellan C; Hernández-Losa J; Peg V; Salcedo M; Gil-Moreno A; Ramon y Cajal S
    Hum Pathol; 2009 Oct; 40(10):1418-26. PubMed ID: 19428047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus-based virotherapy enabled by cellular YB-1 expression in vitro and in vivo.
    Rognoni E; Widmaier M; Haczek C; Mantwill K; Holzmüller R; Gansbacher B; Kolk A; Schuster T; Schmid RM; Saur D; Kaszubiak A; Lage H; Holm PS
    Cancer Gene Ther; 2009 Oct; 16(10):753-63. PubMed ID: 19363467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin inhibits ezrin-mediated metastatic behavior in a murine model of osteosarcoma.
    Wan X; Mendoza A; Khanna C; Helman LJ
    Cancer Res; 2005 Mar; 65(6):2406-11. PubMed ID: 15781656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor growth suppression by adenovirus-mediated introduction of a cell-growth-suppressing gene tob in a pancreatic cancer model.
    Yanagie H; Tanabe T; Sumimoto H; Sugiyama H; Matsuda S; Nonaka Y; Ogiwara N; Sasaki K; Tani K; Takamoto S; Takahashi H; Eriguchi M
    Biomed Pharmacother; 2009 May; 63(4):275-86. PubMed ID: 18657378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.